Systemic lupus erythematosus – Treatment

Go back

Systemic lupus erythematosus is a complex autoimmune disease that requires thoughtful, ongoing care to control symptoms and protect vital organs. While there is no cure, today’s treatment landscape offers more options than ever before—from time-tested medications to innovative therapies in clinical testing—helping many people with lupus lead fuller, healthier lives.

Navigating Treatment Options in Systemic Lupus Erythematosus

Living with systemic lupus erythematosus means managing a condition where your body’s immune system mistakenly attacks healthy tissues. This autoimmune disease, which occurs when the immune system turns against the body instead of protecting it, can affect many different organs including the skin, joints, kidneys, heart, lungs, and brain. Because lupus affects each person differently, treatment must be tailored to individual needs, disease severity, and which organs are involved.[1][3]

The main goals of lupus treatment are to control symptoms, prevent sudden worsening of the disease called flare-ups, and protect organs from long-term damage. Treatment also aims to help people maintain their quality of life and stay as active as possible. Most people with lupus experience periods when symptoms worsen, alternating with times when symptoms improve or even disappear completely. Understanding how to manage these ups and downs is essential to living well with this condition.[7][10]

Doctors consider several factors when creating a treatment plan. These include how active the disease is at any given time, which parts of the body are affected, the severity of symptoms, and how well the patient tolerates certain medications. For some people, mild symptoms affecting mainly the skin and joints can be managed with less aggressive treatments. Others with more serious involvement of organs like the kidneys, heart, or brain need stronger medications to prevent complications that could be life-threatening.[1][14]

Standard Medications That Form the Foundation of Lupus Care

There is no cure for systemic lupus erythematosus, but several medications have become the cornerstone of treatment over decades of medical experience. These therapies work to calm the overactive immune system, reduce inflammation, and prevent organ damage. The choice of medication depends on which symptoms are present and how severe they are.[14]

Hydroxychloroquine is recommended for nearly all patients with lupus, regardless of disease severity. This medication, originally developed to treat malaria, has proven invaluable in managing lupus. It helps prevent flare-ups, protects organs from damage over time, reduces the risk of dangerous blood clots, and may even extend survival. Many people take hydroxychloroquine for years as a long-term preventive measure. Doctors often check blood levels of this drug during regular visits to ensure patients are taking an effective dose, typically aiming for a level between 750 and 1200 nanograms per milliliter.[12][13][15]

Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, are commonly used to relieve joint pain, muscle aches, and inflammation of the lining around the lungs or heart. These medications work by blocking chemicals in the body that cause inflammation and pain. While they can provide significant relief, patients should always discuss their use with a doctor, as NSAIDs can sometimes affect kidney function or cause stomach problems, especially with long-term use.[1][14]

Corticosteroids, most commonly prednisone, are powerful anti-inflammatory medications that quickly suppress the immune system. They can be taken as pills, applied as creams for skin problems, or given as injections. For mild symptoms affecting the skin and joints, doctors prescribe low doses. When lupus affects vital organs like the kidneys or causes serious inflammation, higher doses may be necessary for a short time. A newer approach called pulse therapy uses short bursts of high-dose intravenous steroids to control moderate to severe lupus while trying to limit long-term steroid exposure.[1][11][13]

⚠️ Important
While corticosteroids are highly effective at controlling lupus symptoms, they carry significant risks when used long-term. Side effects can include weight gain, bone thinning, increased infection risk, high blood pressure, and changes in mood. Current treatment guidelines emphasize using the lowest possible dose for the shortest time necessary, and many newer treatment strategies focus on reducing or eliminating steroid dependence altogether.

When hydroxychloroquine and low-dose steroids are not enough to control symptoms, doctors turn to immunosuppressive medications, which are drugs that calm down the immune system more broadly. These include medications like azathioprine, methotrexate, and mycophenolate mofetil. Each works through different mechanisms to reduce immune system activity and prevent it from attacking healthy tissues. The choice among these depends on which organs are affected, potential side effects, and patient factors like plans for pregnancy.[13][15]

Patients with lupus affecting the kidneys—a condition called lupus nephritis—often require more aggressive immunosuppression. Lupus nephritis can develop in up to 60 percent of people with systemic lupus erythematosus, usually within the first five years after symptoms begin. Without proper treatment, kidney inflammation can lead to permanent damage and even kidney failure. Standard treatments for lupus nephritis include combinations of corticosteroids with immunosuppressive drugs, carefully monitored through regular blood and urine tests.[2][15]

Emerging Therapies in Clinical Research

While traditional medications have helped many people with lupus, researchers continue searching for more effective and safer treatments. Recent years have brought exciting advances, with several new medications approved and many more being tested in clinical trials. These innovative approaches target specific parts of the immune system involved in lupus, offering hope for better disease control with fewer side effects.[13][17]

Belimumab was a landmark development, becoming the first new drug approved specifically for lupus in over 50 years when it received regulatory approval in 2011. This biologic medication, which means it is made from living cells rather than chemicals, works by blocking a protein called B-lymphocyte stimulator (BLyS). This protein helps B cells—immune cells that produce harmful antibodies in lupus—survive and multiply. By blocking BLyS, belimumab reduces the number of these problematic B cells. Belimumab is given as an infusion into a vein or as an injection under the skin. Clinical trials showed it can reduce disease activity and decrease the frequency of flare-ups in adults and children with active lupus who are already taking standard medications.[13][15][16]

Anifrolumab, approved in 2021, represents another breakthrough in lupus treatment. This medication targets a pathway involving chemicals called type 1 interferons, which are overactive in many people with lupus and contribute to inflammation. By blocking the receptor for these interferons, anifrolumab dampens this inflammatory signal. In clinical trials, patients receiving anifrolumab along with their standard treatments were more likely to see improvements in their skin rashes, arthritis, and overall disease activity compared to those receiving placebo. This drug is given as an intravenous infusion once a month.[13][16]

For people with lupus nephritis specifically, voclosporin gained approval in 2021 as the first new treatment for this complication in many years. Voclosporin is a calcineurin inhibitor, a class of drugs that suppresses certain immune system pathways. When added to standard treatment with mycophenolate and steroids, voclosporin improved kidney function and reduced protein in the urine—a sign of kidney damage—more effectively than standard treatment alone. This oral medication is taken twice daily and represents an important addition to the limited options for treating lupus-related kidney disease.[13][16]

Perhaps the most exciting development on the horizon involves a completely different approach called CAR T-cell therapy. This treatment, already used successfully in certain cancers, involves collecting a patient’s own immune cells, genetically modifying them in a laboratory to target and destroy B cells, then returning them to the patient’s body. Early results from small studies in patients with severe lupus that didn’t respond to conventional treatments have been remarkable, with some patients achieving complete remission of their disease. While this therapy is still experimental and carries risks including serious infections, it offers hope for a potential “reset” of the immune system in difficult cases.[17]

Researchers are also testing low-dose interleukin-2 (IL-2), a protein that may help restore balance to the immune system by boosting regulatory T cells—immune cells that normally keep the immune response in check. Unlike other immunosuppressive treatments that broadly dampen immunity, this approach aims to restore normal immune function. Clinical trials are ongoing to determine the most effective dose and which patients might benefit most from this therapy.[17]

Another medication under investigation is obinutuzumab, an antibody that targets CD20, a protein found on B cells. This drug is designed to more completely deplete B cells compared to similar medications. Early Phase II trials are evaluating whether this more thorough B-cell depletion can lead to better disease control. Researchers are also studying various kinase inhibitors—small molecules that block specific enzymes involved in immune system signaling. These oral medications might offer advantages in convenience and cost compared to intravenous biologic drugs.[13][17]

Clinical trials for lupus are conducted worldwide, including in the United States, Europe, and Poland. They typically progress through three phases. Phase I trials test primarily for safety in small groups of patients. Phase II trials involve larger numbers of patients and begin to assess whether the treatment is effective at controlling lupus symptoms. Phase III trials compare the new treatment directly against standard therapies in hundreds or thousands of patients to determine if the new approach is better, worse, or equivalent to existing options. Patients interested in participating in clinical trials should discuss this option with their rheumatologist, as trials often have specific eligibility criteria based on disease severity, previous treatments, and other health factors.[6][13]

The Importance of Regular Monitoring and the Treat-to-Target Approach

Successful lupus management requires more than just taking medications—it demands regular monitoring to catch problems early and adjust treatment as needed. People with active lupus should see their rheumatologist every one to three months, while those with well-controlled disease may be seen less frequently. Each visit typically includes measuring blood pressure, since lupus and some lupus medications can affect cardiovascular health.[12]

Regular laboratory testing is essential. Blood tests check for levels of various antibodies, including anti-double-stranded DNA antibodies, which often increase when lupus is more active. Tests also measure complement proteins (C3 and C4), components of the immune system that are often low during flare-ups. A complete blood count looks for anemia or low levels of white blood cells or platelets, which can occur in lupus. Kidney and liver function tests ensure these organs are working properly. Urinalysis checks for protein or blood in the urine, early signs of kidney involvement.[1][12]

Modern lupus care increasingly follows a “treat-to-target” strategy. Rather than simply treating symptoms as they arise, this approach sets a specific goal—ideally complete remission, meaning no signs of disease activity, or at minimum a state of low disease activity. The treatment plan is then adjusted regularly based on objective measures of disease activity until that target is reached. This proactive approach, combined with efforts to minimize corticosteroid use, has been shown to improve long-term outcomes and quality of life.[12][13]

Most common treatment methods

  • Antimalarial medications
    • Hydroxychloroquine is recommended for all patients with lupus to prevent flare-ups, organ damage, blood clots, and improve long-term survival
    • Blood levels are monitored to ensure effective dosing, typically targeting 750-1200 ng/mL
    • This medication can be continued safely during pregnancy to control disease activity and reduce complications
  • Corticosteroids
    • Low doses (such as prednisone) are used for skin rashes and joint symptoms
    • Higher doses are reserved for serious organ involvement including kidneys, heart, lungs, or brain
    • Corticosteroid creams can be applied directly to skin lesions
    • Pulse therapy with high-dose intravenous steroids provides short bursts of treatment for moderate to severe disease
    • Current guidelines emphasize using the lowest possible dose for the shortest duration
  • Immunosuppressive medications
    • Drugs like azathioprine, methotrexate, and mycophenolate mofetil calm the overactive immune system
    • These are used when hydroxychloroquine and low-dose steroids are not sufficient to control symptoms
    • Specific combinations are chosen based on which organs are affected and individual patient factors
  • Biologic therapies
    • Belimumab blocks B-lymphocyte stimulator (BLyS), reducing problematic B cells that produce harmful antibodies
    • Anifrolumab blocks type 1 interferon receptors, dampening inflammatory signals
    • These medications are given by infusion or injection and have shown effectiveness in reducing disease activity and flare-ups
  • Targeted kidney treatments
    • Voclosporin, a calcineurin inhibitor approved in 2021, is specifically for lupus nephritis
    • It is added to standard treatment with mycophenolate and steroids to improve kidney function
    • Regular monitoring through blood and urine tests is essential for patients with kidney involvement
  • Nonsteroidal anti-inflammatory drugs (NSAIDs)
    • Medications like ibuprofen help relieve joint pain, muscle aches, and inflammation around the lungs or heart
    • These should be used with medical supervision due to potential effects on kidney function

Living Well With Lupus Beyond Medications

While medications form the foundation of lupus treatment, lifestyle choices play an equally important role in managing the disease. Small changes in daily habits can significantly reduce the frequency and severity of flare-ups and improve overall well-being.[18][21]

Sun protection is crucial because ultraviolet light is one of the most common triggers for lupus flares. Many people with lupus develop a characteristic butterfly-shaped rash across the cheeks and nose after sun exposure, and UV rays can also trigger more serious systemic symptoms. Using broad-spectrum sunscreen with an SPF of at least 50, wearing wide-brimmed hats, covering arms and legs with clothing, and avoiding peak sun hours between 10 AM and 4 PM can all help prevent photosensitivity reactions. It’s worth noting that fluorescent and halogen lights can also trigger symptoms in some people, so limiting exposure to these indoor light sources may be beneficial.[9][18][21]

Rest and energy management are essential, as crushing fatigue is one of the most common and debilitating symptoms of lupus. Getting seven to nine hours of quality sleep each night, taking short breaks throughout the day, and learning to pace activities can help conserve energy. This means not pushing too hard on days when you feel good, as overexertion often leads to a crash later. Learning to say no to some activities and asking for help when needed isn’t a sign of weakness—it’s smart disease management.[18][21]

Stress is another powerful trigger for lupus flares. While it’s impossible to eliminate stress completely, techniques like meditation, deep breathing exercises, gentle yoga, or even simple activities like taking a warm bath or spending time in nature can help keep stress levels in check. Finding healthy ways to cope with the emotional challenges of living with a chronic illness is equally important. Many people benefit from support groups, either in person or online, where they can connect with others who truly understand what they’re going through.[9][18][21]

Smoking is particularly harmful for people with lupus, as it can trigger flares, worsen symptoms, and increase the risk of cardiovascular disease and other complications. Anyone with lupus who smokes should discuss smoking cessation programs and medications with their doctor to help quit.[9][18]

Nutrition plays a supportive role in managing lupus. While no specific diet cures the disease, eating a balanced diet rich in fruits, vegetables, whole grains, and lean proteins provides the nutrients needed for overall health. Some evidence suggests that foods high in omega-3 fatty acids—found in fatty fish like salmon, walnuts, flaxseeds, and chia seeds—may help reduce inflammation. A Mediterranean-style diet, emphasizing these foods along with olive oil, has shown promise in reducing inflammatory markers. Conversely, limiting red meat, fried foods, and simple carbohydrates like white bread and sugary snacks may help keep inflammation in check. Some people with lupus should avoid alfalfa sprouts and Echinacea supplements, as these may trigger immune system activity.[18][21]

Exercise offers multiple benefits for people with lupus, including reducing stress, improving mood, fighting fatigue, maintaining healthy weight, and protecting heart health. The key is finding the right balance—gentle activities like walking, swimming, or stretching are often well-tolerated. Starting slowly and gradually increasing activity, always listening to your body and resting when needed, can help you build strength and endurance without triggering a flare. It’s important to discuss exercise plans with your doctor, especially if you have joint problems or organ involvement.[18][21]

⚠️ Important
Infections are among the leading causes of serious complications and death in people with lupus, partly because the disease itself affects immunity and partly because many lupus medications suppress the immune system. Staying current with vaccinations—including pneumococcal vaccines, shingles vaccine, annual flu shots, COVID-19 vaccines, and human papillomavirus vaccine—is essential. Contact your doctor promptly if you develop signs of infection such as fever, persistent cough, or unusual symptoms.

Working With Your Healthcare Team

Managing lupus effectively requires partnership between patient and healthcare providers. A rheumatologist, a doctor specializing in autoimmune diseases and conditions affecting joints and connective tissues, typically leads the treatment team. However, because lupus can affect so many different organs, care often involves collaboration with specialists in nephrology for kidney problems, cardiology for heart issues, dermatology for skin manifestations, and other fields as needed.[7]

Open communication with your healthcare team is vital. If you’re experiencing new symptoms, side effects from medications, or if you think a medication isn’t working, speak up. Keep a diary of symptoms to help identify patterns and triggers. Bring a list of questions to appointments. Don’t hesitate to ask for clarification if you don’t understand something about your disease or treatment. The more informed you are, the better you can participate in decisions about your care.[18]

Taking medications exactly as prescribed—even when you feel well—is one of the most important things you can do to prevent flare-ups and organ damage. It can be tempting to skip doses when symptoms improve, but many lupus medications work by maintaining steady levels in your body over time. If you’re having trouble remembering to take medications, experiencing side effects, or facing cost barriers, discuss these challenges with your doctor. Solutions might include simplifying your medication schedule, switching to different formulations, or connecting with resources for financial assistance.[18]

Pregnancy requires special planning for women with lupus. While many women with lupus have healthy pregnancies and babies, the condition increases risks of complications including miscarriage, preeclampsia, preterm birth, and fetal growth restriction. Preconception counseling with your rheumatologist and obstetrician is essential to optimize disease control before pregnancy, adjust medications to those safe during pregnancy (hydroxychloroquine can and should be continued), and plan for close monitoring throughout pregnancy and after delivery.[12][21]

Ongoing Clinical Trials on Systemic lupus erythematosus

  • Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Denmark Finland France Germany +9
  • A Study of Idecabtagene Vicleucel CAR-T Cell Therapy for Patients with Autoimmune Diseases That Did Not Respond to B Cell Removal Treatment

    Recruiting

    1 1 1
    Investigated drugs:
    Germany
  • Evaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Greece +7
  • Study of Mosunetuzumab Treatment in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on the Safety of CNTY-101 and Aldesleukin for Patients with Active Autoimmune Diseases: Lupus, Scleroderma, and Myositis

    Recruiting

    1 1 1
    Investigated drugs:
    Germany
  • Study on the Effects of Rituximab and Obinutuzumab in Patients with Systemic Lupus Erythematosus (SLE)

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Effects of Belimumab for Patients with Systemic Lupus Erythematosus (SLE)

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Long-term Safety Study of AUTO4 and Rituximab in Patients with Potential Malignancy Treated with Autologous CAR T Cell Therapy

    Recruiting

    1 1 1
    Spain
  • Study on the Safety of MB-CART19.1 for Patients with Active Systemic Lupus Erythematosus, Systemic Sclerosis, or Dermatomyositis/Polymyositis

    Recruiting

    1 1
    Germany
  • Study on the Effects of Belimumab and Rituximab for Patients with Severe Systemic Lupus Erythematosus

    Recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands

References

https://medlineplus.gov/ency/article/000435.htm

https://www.lupus.org/resources/what-is-systemic-lupus-erythematosus-sle

https://my.clevelandclinic.org/health/diseases/4875-lupus

https://www.ncbi.nlm.nih.gov/books/NBK535405/

https://www.mayoclinic.org/diseases-conditions/lupus/symptoms-causes/syc-20365789

https://emedicine.medscape.com/article/332244-overview

https://www.cdc.gov/lupus/about/index.html

https://www.nm.org/conditions-and-care-areas/rheumatology/systemic-lupus-erythematosus-sle

https://www.nhs.uk/conditions/lupus/

https://my.clevelandclinic.org/health/diseases/4875-lupus

https://www.mayoclinic.org/diseases-conditions/lupus/diagnosis-treatment/drc-20365790

https://www.aafp.org/pubs/afp/issues/2023/0400/systemic-lupus-erythematosus.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC10261264/

https://medlineplus.gov/ency/article/000435.htm

https://emedicine.medscape.com/article/332244-treatment

https://www.lupus.org/news/american-college-of-rheumatology-new-systemic-lupus-erythematosus-guideline

https://www.nature.com/articles/s41573-025-01242-0

https://www.lupus.org/resources/dos-and-donts-for-living-well-with-lupus

https://my.clevelandclinic.org/health/diseases/4875-lupus

https://arthritissj.com/helping-patients-with-sle-thrive-tips-for-living-better-with-lupus/

https://womenshealth.gov/lupus/living-lupus

https://www.parkview.com/blog/how-to-care-for-yourself-when-you-have-lupus

https://www.cdc.gov/lupus/about/index.html

https://www.bassmedicalgroup.com/blog-post/coping-strategies-for-living-with-lupus

https://www.webmd.com/lupus/lupus-tips-everyday-living

https://rheumatology.org/patient-blog/lupus-self-management-take-back-control

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can lupus be cured?

No, there is currently no cure for systemic lupus erythematosus. However, with proper treatment, many people with lupus can achieve remission, where they have no signs of disease activity, or maintain low disease activity. More than 90 percent of people with lupus live normal, healthy lives with appropriate medical care and lifestyle management.

Will I need to take medication for the rest of my life?

Most people with lupus require long-term medication to prevent flare-ups and organ damage. Hydroxychloroquine is typically recommended for all lupus patients as a maintenance therapy, even during periods of remission. Other medications may be adjusted over time based on disease activity, with some potentially reduced or stopped under careful medical supervision when the disease is well-controlled.

What are the side effects of lupus medications?

Side effects vary depending on the medication. Hydroxychloroquine is generally well-tolerated but requires regular eye exams. Corticosteroids can cause weight gain, bone thinning, increased infection risk, and mood changes, especially with long-term use. Immunosuppressive drugs may increase infection risk and require regular blood monitoring. Newer biologic medications may cause infusion reactions. Your doctor will discuss specific risks and benefits of each medication and monitor you regularly for side effects.

How can I tell if a lupus flare is coming?

Common warning signs of an impending flare include increased fatigue beyond your usual tiredness, new or worsening joint pain and swelling, developing a rash or noticing skin changes, running a low-grade fever without obvious infection, experiencing more headaches, and generally feeling unwell. Keeping a symptom diary can help you recognize your personal patterns and triggers, allowing you to contact your doctor early and potentially prevent a full flare.

Can I participate in a clinical trial for new lupus treatments?

Many clinical trials are ongoing worldwide to test new lupus treatments, including in the United States, Europe, and other regions. Eligibility depends on factors like your disease severity, previous treatments, and overall health. Talk to your rheumatologist about whether participating in a clinical trial might be appropriate for you. Clinical trials offer access to promising new therapies before they’re widely available, though they may involve additional monitoring visits and some uncertainty about effectiveness.

🎯 Key takeaways

  • Hydroxychloroquine is recommended for nearly all lupus patients as it prevents flare-ups, protects organs, and improves long-term survival, making it a cornerstone therapy regardless of disease severity.
  • Three new medications were approved for lupus in 2021 alone—belimumab, anifrolumab, and voclosporin—representing the most significant treatment advances in over 50 years.
  • Modern lupus care follows a “treat-to-target” approach, aiming for complete remission or low disease activity rather than simply managing symptoms as they arise.
  • Experimental CAR T-cell therapy has achieved complete remissions in some patients with severe lupus, offering hope for an immune system “reset” in difficult cases.
  • Sun protection is crucial as ultraviolet light is one of the most common and avoidable triggers for lupus flares—wearing SPF 50+ sunscreen and protective clothing can significantly reduce symptom worsening.
  • Infections are a leading cause of serious complications in lupus, making vaccinations essential protection—staying current with pneumococcal, shingles, flu, and COVID-19 vaccines can be lifesaving.
  • Current treatment strategies emphasize minimizing long-term corticosteroid use due to significant side effects, with newer medications and approaches helping patients reduce or eliminate steroid dependence.
  • People with lupus affecting their kidneys (lupus nephritis) now have voclosporin as a targeted treatment option, the first new drug specifically for this complication in many years.